Agency Business Briefs: Cephalon, Draftfcb, Cline Davis & Mann, inVentiv Health and ParagonRx

Share this article:
Cephalon has consolidated its oncology business into Interpublic Group's Draftfcb. The franchise includes Trisenox, which was with WPP's Sudler & Hennessey, and Treanda, which was with Omnicom's LyonHeart. It's a purely professional-facing assignment, as those brands are not currently advertised to consumers. Draftfcb, which previously handled advertising for Nuvigil, will take over the oncology business sometime this quarter, Cephalon said.

Dr. Nan Hayworth, a former Cline, Davis & Mann exec, left the shop to run for US Congress as a Republican in New York's 19th Congressional district. That Hudson Valley district is currently held by Democrat John Hall. An ophthalmologist, Dr. Hayworth was VP medical and scientific affairs at CDM until she launched her Congressional bid.

InVentiv Health acquired ParagonRx, a consulting company specializing in pharma risk management and optimizing medication use. The acquisition is aimed at bolstering inVentiv's Risk Evaluation and Mitigation Strategy offering . In the past year, the network noted, more than a quarter of all new drug approvals in the US included an FDA-approved REMS program.

Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters